Cancer

Title
I-SPY 2 Trial: Comparison of Standard Chemotherapy and Standard Chemotherapy with Investigational Drugs
Trial Number
202755051910
Number of Participants
800
Principal Investigator

Kathy S. Albain

M.D.
Hematology/Oncology
Professor
Eligibility

Adult females =18 years old with the following criterias may be eligible: Histologically documented breast cancer; no prior cytotoxic regimens for this malignancy; ECOG performance status 0 - 1; willing and able to undergo core biopsy of the primary breast lesion to assess baseline biomarkers to determine eligibility for treatment phase; non-pregnant and non-lactating;
additional requirements in the protocol.

Purpose

The purpose of this study is to determine how women with breast cancer will respond to standard chemotherapy versus standard chemotherapy with investigational drugs.

Enrollment

(708) 327-3102

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.